Brief: Celyad Announces Good Results For CYAD-02 In CYCLE-1 Trial

Celyad Oncology SA

13/01/2020 06:05

Jan 13 (Reuters) - CELYAD SA  CYAD.BR :
    * CELYAD SUCCESSFULLY DOSES FIRST PATIENT WITH CYAD-02 IN
CYCLE-1
TRIAL FOR R/R AML AND MDS
    * CELYAD SA - PRELIMINARY DATA FROM PHASE 1 CYCLE-1 TRIAL
ARE
EXPECTED DURING SECOND HALF 2020

Source text for Eikon:  ID:nBw2CgD6a 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))